Risk stratification of prostate cancer with MRI and prostate-specific antigen density-based tool for personalized decision making

Abstract

This real-world dataset from a large UK-based cohort confirms that combining MRI scoring with PSA density for risk stratification enables safe biopsy avoidance and limits the over-diagnosis of insignificant cancers.